Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Inventory Average (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Inventory Average came in at $14.9 billion in Q2 2026, up 14.02% year-over-year from $13.0 billion in Q2 2025, and up 3.31% quarter-over-quarter from $14.4 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Inventory Average (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Inventory Average across 18 years of filings, most recently posting $14.9 billion for Q2 2026.

  • In Q2 2026, Inventory Average rose 14.02% year-over-year to $14.9 billion; the TTM figure through Jun 2026 stood at $14.9 billion (up 14.02% YoY), while the FY2025 annual figure was $13.3 billion, up 12.74% from the prior year.
  • Inventory Average came in at $14.9 billion for Q2 2026 at Johnson & Johnson, up from $14.4 billion in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $14.9 billion in Q2 2026 to a low of $10.4 billion in Q1 2022.
  • Average Inventory Average over 5 years is $12.3 billion, with a median of $12.0 billion recorded in 2023.
  • Year-over-year, Inventory Average dropped 8.35% in 2024 and climbed 14.62% in 2026.
  • Over 5 years, Inventory Average stood at $11.6 billion in 2022, then dropped by 3.17% to $11.2 billion in 2023, then increased by 11.92% to $12.5 billion in 2024, then increased by 13.14% to $14.2 billion in 2025, then rose by 4.91% to $14.9 billion in 2026.
  • Per Business Quant data, the three most recent Inventory Average figures were $14.9 billion in Q2 2026, $14.4 billion in Q1 2026, and $14.2 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 14.86 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 5.09 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 6.34 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 6.25 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 10.31 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 114.08 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 186.05 Mn
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 84.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 14.86 Bn
Mar 29, 2026 14.39 Bn
Dec 28, 2025 14.17 Bn
Sep 28, 2025 13.78 Bn
Jun 29, 2025 13.04 Bn
Mar 30, 2025 12.55 Bn
Dec 29, 2024 12.52 Bn
Sep 29, 2024 12.39 Bn
Jun 30, 2024 11.78 Bn
Mar 31, 2024 11.28 Bn
Dec 31, 2023 11.19 Bn
Oct 1, 2023 12.04 Bn
Jul 2, 2023 12.85 Bn
Apr 2, 2023 11.54 Bn
Jan 1, 2023 10.97 Bn
Oct 2, 2022 11.56 Bn
Jul 3, 2022 11.21 Bn
Apr 3, 2022 10.69 Bn
Jan 2, 2022 10.39 Bn
Oct 3, 2021 10.24 Bn